Medicine (Apr 2022)

Injection granuloma mimicking soft tissue sarcoma following seasonal influenza vaccine administration

  • Gregory R. Toci, MD,
  • Christa L. LiBrizzi, MD,
  • Jarred A. Bressner, MD,
  • Adam Scott Levin, MD,
  • Carol D. Morris, MD, MS,
  • Maya Saranathan.

DOI
https://doi.org/10.1097/MD.0000000000028942
Journal volume & issue
Vol. 101, no. 16
p. e28942

Abstract

Read online

Abstract. Rationale:. Soft tissue masses are common within the general population with a minority diagnosed as soft tissue neoplasms. Differing between benign and malignant soft tissue processes can be a challenge given the overlapping clinical and imaging characteristics. We present the case of a 69-year-old female referred to the Orthopaedic Oncology Service for evaluation of a suspected soft tissue sarcoma in the upper arm. Patient Concerns:. She reported a mass localized over the deltoid with associated tenderness 1 month after influenza vaccination. Diagnosis:. After thorough consideration of the patient's clinical course, history, advanced imaging, and physical examination, the diagnosis of injection granuloma associated with recent influenza vaccination was considered. Interventions:. Biopsy was deferred and close interval follow-up with clinical and imaging evaluation revealed a resolving process. Outcomes:. The patient was followed until complete resolution of all symptoms, which occurred 5 months after initial presentation. Lessons:. It was hypothesized that due the patient's body habitus, the injection contents intended for intramuscular administration remained in the subcutaneous tissues and elicited a granulomatous reaction. This case highlights several important factors for physicians to consider in the work up of suspicious masses for which injection granuloma is on the differential diagnosis.